Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
McKinsey
Medtronic
Dow
AstraZeneca

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxamine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Pyridoxamine: Sponsors, patents, clinical trial progress

Pyridoxamine is an investigational drug.

There have been 6 clinical trials for Pyridoxamine. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.

The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are NephroGenex, Inc., Medpace, Inc., and Collaborative Study Group (CSG).

There is one US patent protecting this investigational drug and ten international patents.

Recent Clinical Trials for Pyridoxamine
TitleSponsorPhase
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With PyridoxamineColumbia UniversityN/A
Pyridorin in Diabetic NephropathyCollaborative Study Group (CSG)Phase 3
Pyridorin in Diabetic NephropathyMedpace, Inc.Phase 3

See all Pyridoxamine clinical trials

Clinical Trial Summary for Pyridoxamine

Top disease conditions for Pyridoxamine
Top clinical trial sponsors for Pyridoxamine

See all Pyridoxamine clinical trials

US Patents for Pyridoxamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyridoxamine   Start Trial Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (Acton, AU) GRAINS RESEARCH AND DEVELOPMENT CORPORATION (Barton, AU) NUSEED PTY LTD. (Laverton North, AU)   Start Trial
Pyridoxamine   Start Trial Compounds useful for the treatment of metabolic disorders and synthesis of the same North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)   Start Trial
Pyridoxamine   Start Trial Particle detecting device AZBIL CORPORATION (Chiyoda-ku, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Baxter
McKinsey
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.